Elevated DHEA-S Levels May Shorten Lifespan in Men, No Impact Observed in Women
New genetic research links higher DHEA-S hormone levels to shorter lifespan in men, highlighting gender-specific health effects and raising questions about supplement regulation.
Recent research indicates a significant link between higher levels of the hormone dehydroepiandrosterone sulfate (DHEA-S) and reduced lifespan in men. The study, led by Professor Mary Schooling from CUNY School of Public Health, employed a Mendelian randomization approach, analyzing genetic data from large European cohorts to determine causal relationships while minimizing confounding factors.
The findings revealed that genetically higher DHEA-S levels are associated with increased blood pressure and a shorter lifespan among men. Interestingly, the same connection was not observed in women, suggesting a gender-specific effect.
DHEA-S is a precursor to male and female sex hormones, such as testosterone, which implies that elevated levels could influence health outcomes differently across genders. The study's results align with FDA warnings about testosterone therapy potentially increasing blood pressure in men. These insights raise important questions about the regulatory status and over-the-counter availability of DHEA supplements in the United States.
While the evidence on DHEA-S and lifespan has been limited, this study provides robust genetic data supporting its impact on men's health. Further research is needed to explore potential interventions and guideline considerations regarding DHEA supplementation.
Source: Medical Xpress
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Decade-Long Study Finds Stereotactic Body Radiation Therapy Matches Surgery Outcomes for Early-Stage Lung Cancer
A 10-year study shows stereotactic body radiation therapy provides survival outcomes comparable to surgery for early-stage lung cancer, with added quality-of-life benefits, emphasizing its role as a key treatment option.
Hidden Risks of Bowel Cancer in Common Colorectal Polyps
New research reveals that individuals with both adenomas and serrated polyps have a significantly higher risk of developing bowel cancer. Early detection and regular colonoscopies are crucial for prevention.
Increased Risk of Intraocular Inflammation with Aflibercept Injections in Real-World Practice
Real-world use of aflibercept injections shows a higher incidence of mild intraocular inflammation compared to clinical trials, emphasizing the need for careful patient monitoring and education.